78
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Does titration of mitomycin C as an adjunct to trabeculectomy significantly influence the intraocular pressure outcome?

, &
Pages 81-87 | Published online: 25 Nov 2022

References

  • ChenCWEnhanced intraocular pressure controlling effectiveness of trabeculectomy by local application of mitomycin CTrans Asia Pac Acad Ophthalmol198391727
  • ChenCWHuangHTBairJSTrabeculectomy with simultaneous topical application of mitomycin-C in refractory glaucomaJ Ocul Pharmacol19906175822127056
  • KitazawaYKawaseKMatsushitaHTrabeculectomy with mitomycin: a comparative study with fluorouracilArch Ophthalmol1991109169381841578
  • SkutaGLBeesonCCHigginothamEJIntraoperative mitomycin versus postoperative 5-fluorouracil in high-risk glaucoma filtering surgeryOphthalmology199299438441565457
  • KatzGJHigginbothamEJLichterPRMitomycin C versus 5-Fluorouracil in high-risk glaucoma filtering surgeryOphthalmology1995103126399097762
  • PalmerSSMitomycin as adjunct chemotherapy with trabeculectomyOphthalmology199198317212023752
  • El SayyadFBelmekkiMHelalMSimultaneous subconjunctival and subscleral mitomycin-C application in trabeculectomyOphthalmology200010729830210690829
  • NuijtsRMVernimmenRCJWebersCAMitomycin C primary trabeculectomy in primary glaucoma of white patientsJ Glaucoma1997629379327347
  • ScottIUGreenfieldDSSchiffmanJOutcomes of primary trabeculectomy with the use of adjunctive mitomycinArch Ophthalmol1998116286919514480
  • CohenJSNovackGDLiZLThe role of mitomycin treatment duration and previous intraocular surgery on the success of trabeculectomy surgeryJ Glaucoma19976399075073
  • PerkinsTWGangnonRLaddWTrabeculectomy with mitomycin C: intermediate-term resultsJ Glaucoma1998723069713779
  • ShieldsMBScroggsMWSloopCMClinical and histopathologic observations concerning hypotony after trabeculectomy with adjunctive mitomycin CAm J Ophthalmol1993116673838250068
  • StoneRTHerndonLWAllinghamRRResults of trabeculectomy with 0.3 mg/ml mitomycin C titrating exposure times based on risk factors for failureJ Glaucoma1998739449493114
  • NeelakantanARaoBSVijayaLEffect of the concentration and duration of application of mitomycin C in trabeculectomyOphthalmic Surg1994256126157831005
  • CheungJCWrightMMMuraliSIntermediate-term outcome of variable dose mitomycin C filtering surgeryOphthalmology199710414399022119
  • RobinALRamakrishnanRKrishnadasRA long-term dose-response study of mitomycin in glaucoma filtration surgeryArch Ophthalmol1997115969739258217
  • KitazawaYSuemori-MatsushitaHYamamotoTLow-dose and high-dose mitomycin trabeculectomy as an initial surgery in primary open-angle glaucomaOphthalmology1993100162488233386
  • SandersSPCantorLBDoblerAAMitomycin C in higher risk trabeculectomy: a prospective comparison of 0.2- to 0.4-mg/cc dosesJ Glaucoma19998193810376260
  • JampelHDEffect of brief exposure to mitomycin C on viability and proliferation of cultured human Tenon’s capsule fibroblastsOphthalmology199299147161407982
  • MegevandGSSalmonJFScholtzRPThe effect of reducing the exposure time of mitomycin C in glaucoma filtering surgeryOphthalmology199510284907831047
  • KimYYSextonRMShinDHOutcomes of primary phakic trabeculectomies without versus with 0.5- to 1-minute versus 3- to 5-minute mitomycin CAm J Ophthalmol1998126755629859998
  • ZachariaPTDeppermannSRSchumanJSOcular hypotony after trabeculectomy with mitomycin CAm J Ophthalmol(93);116314268357056
  • SturmerJBroadwayDCHitchingsRAYoung patient trabeculectomy: assessment of risk factors for failureOphthalmology1993100928398510908
  • StamperRLMcMenemyMGLiebermanMFHypotonous maculopathy after trabeculectomy with subconjunctival 5-fluorouracilAm J Ophthalmol1992114544531309184
  • FanninLASchiffmanJCBudenzDLRisk factors for hypotony maculopathyOphthalmology200311011859112799246